Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 22, 2021
Reporting Period: Single event date (November 22, 2021)
Business Context: The filing serves as a Regulation FD disclosure to announce a scheduled presentation by the Company's President and CEO, Jasbir Seehra, at the Piper Sandler 33rd Annual Virtual Healthcare Conference.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely discloses the scheduling of a conference presentation.
Guidance, Outlook, and Management Commentary
- Event: CEO Jasbir Seehra is scheduled to present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.
- Availability: A recording of the fireside chat presentation became available on November 22, 2021, at 10:00 am ET.
- Disclosure Status: The information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the availability and content of the fireside chat recording on the Piper Sandler platform or the Company's investor relations site.
- Review the attached press release (Exhibit 99.1) for specific details regarding the presentation topics.
- Confirm that no other material events were disclosed in this specific 8-K filing beyond the conference announcement.